Helius Medical Technologies Inc
NASDAQ:HSDT

Watchlist Manager
Helius Medical Technologies Inc Logo
Helius Medical Technologies Inc
NASDAQ:HSDT
Watchlist
Price: 3.21 USD 6.29% Market Closed
Market Cap: $132.6m

Operating Margin

-1 635.5%
Current
Improving
by 809.6%
vs 3-y average of -2 445.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 635.5%
=
Operating Income
$-15.4m
/
Revenue
$941k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 635.5%
=
Operating Income
$-15.4m
/
Revenue
$941k

Peer Comparison

Country Company Market Cap Operating
Margin
US
Helius Medical Technologies Inc
NASDAQ:HSDT
129.4m USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.7B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.6B USD
Loading...
US
Stryker Corp
NYSE:SYK
134.5B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.9B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.8B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.6B USD
Loading...

Market Distribution

Lower than 95% of companies in the United States of America
Percentile
5th
Based on 14 112 companies
5th percentile
-1 635.5%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Helius Medical Technologies Inc
Glance View

Market Cap
132.6m USD
Industry
Health Care

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania. The company went IPO on 2014-06-27. The firm focuses on developing, licensing or acquiring non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The firm's product, Portable Neuromodulation Stimulator (PoNS) is a class II, non-implantable medical device intended for use as a short-term treatment (14 weeks) of gait deficit due to symptoms from multiple sclerosis (MS), and balance deficit due to mild-to-moderate traumatic brain injury (mmTBI) and is to be used in conjunction with supervised therapeutic exercise (PoNS Treatment). The firm's subsidiaries include Helius Medical, Inc., Helius Medical Technologies (Canada), Inc., Helius NeuroRehab, Inc., Helius Canada Acquisition Ltd. and Heuro Canada, Inc.

HSDT Intrinsic Value
3.87 USD
Undervaluation 17%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1 635.5%
=
Operating Income
$-15.4m
/
Revenue
$941k
What is Helius Medical Technologies Inc's current Operating Margin?

The current Operating Margin for Helius Medical Technologies Inc is -1 635.5%, which is above its 3-year median of -2 445.1%.

How has Operating Margin changed over time?

Over the last 3 years, Helius Medical Technologies Inc’s Operating Margin has increased from -2 101.3% to -1 635.5%. During this period, it reached a low of -4 932.2% on Jun 30, 2025 and a high of -1 332.5% on Sep 30, 2023.

Back to Top